Emerging Molecular Therapies: Drugs Interfering With Signal Transduction Pathways

作者: Alison H.M. Reid , Richard Baird , Paul Workman

DOI: 10.1007/978-1-59745-470-4_17

关键词:

摘要:

参考文章(437)
Blundell Tl, Structure-based drug design. Nature. ,vol. 384, pp. 23- 26 ,(1996) , 10.1038/384023A0
Christopher J. Torrance, Peta E. Jackson, Elizabeth Montgomery, Kenneth W. Kinzler, Bert Vogelstein, Allan Wissner, Maria Nunes, Philip Frost, Carolyn M. Discafani, Combinatorial chemoprevention of intestinal neoplasia. Nature Medicine. ,vol. 6, pp. 1024- 1028 ,(2000) , 10.1038/79534
Rhoda Molife, Ian Collins, Paul Workman, Stan B. Kaye, Rational Drug Design of Small Molecule Anticancer Agents: Early Clinical Development The Cancer Handbook. ,(2007) , 10.1002/9780470025079.CHAP315
Judith S. Sebolt-Leopold, David T. Dudley, Roman Herrera, Keri Van Becelaere, Amy Wiland, Richard C. Gowan, Haile Tecle, Stephen D. Barrett, Alexander Bridges, Sally Przybranowski, W.R. Leopold, Alan R. Saltiel, Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo. Nature Medicine. ,vol. 5, pp. 810- 816 ,(1999) , 10.1038/10533
P. C. Nowell, A minute chromosome in human chronic granulocytic leukemia Science. ,vol. 132, pp. 1497- ,(1960)
Paul Carter, Improving the efficacy of antibody-based cancer therapies Nature Reviews Cancer. ,vol. 1, pp. 118- 129 ,(2001) , 10.1038/35101072
Gerard I. Evan, Karen H. Vousden, Proliferation, cell cycle and apoptosis in cancer Nature. ,vol. 411, pp. 342- 348 ,(2001) , 10.1038/35077213